ZA96403B - Racemisation - Google Patents

Racemisation

Info

Publication number
ZA96403B
ZA96403B ZA96403A ZA96403A ZA96403B ZA 96403 B ZA96403 B ZA 96403B ZA 96403 A ZA96403 A ZA 96403A ZA 96403 A ZA96403 A ZA 96403A ZA 96403 B ZA96403 B ZA 96403B
Authority
ZA
South Africa
Prior art keywords
compound
alkylated
piperidine
racemisation
racemised
Prior art date
Application number
ZA96403A
Other languages
English (en)
Inventor
Ulrich Conrad Dyer
Martin Woods
Marianne Langston
Original Assignee
Chiroscience Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chiroscience Ltd filed Critical Chiroscience Ltd
Publication of ZA96403B publication Critical patent/ZA96403B/xx

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Hydrogenated Pyridines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Beans For Foods Or Fodder (AREA)
  • Rolling Contact Bearings (AREA)
  • Optical Head (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
ZA96403A 1995-01-18 1996-01-18 Racemisation ZA96403B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9501071.6A GB9501071D0 (en) 1995-01-18 1995-01-18 Racemisation

Publications (1)

Publication Number Publication Date
ZA96403B true ZA96403B (en) 1997-01-20

Family

ID=10768271

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA96403A ZA96403B (en) 1995-01-18 1996-01-18 Racemisation

Country Status (20)

Country Link
EP (1) EP0804417B1 (xx)
JP (1) JP4015696B2 (xx)
KR (1) KR100404390B1 (xx)
CN (1) CN1172912C (xx)
AT (1) ATE242214T1 (xx)
AU (1) AU701221B2 (xx)
BR (1) BR9606821A (xx)
CA (1) CA2208522C (xx)
DE (1) DE69628540T2 (xx)
DK (1) DK0804417T3 (xx)
ES (1) ES2201166T3 (xx)
FI (1) FI117437B (xx)
GB (1) GB9501071D0 (xx)
HU (1) HU227426B1 (xx)
MX (1) MX9705428A (xx)
NO (1) NO308843B1 (xx)
PL (1) PL184091B1 (xx)
PT (1) PT804417E (xx)
WO (1) WO1996022281A1 (xx)
ZA (1) ZA96403B (xx)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0002246A (pt) 2000-04-06 2003-04-15 Cristalia Prod Quimicos Farm Processo de obtenção dos enantiÈmeros da bupivacaìna racêmica, processo de obtenção de composições farmacêuticas a base de levobupivacaìna: composições farmacêuticas a base de levobupivacaìna formuladas nas formas básicas ou sais farmaceuticamente aceitáveis e utilização das composições farmacêuticas a base de levobupivacaìna formuladas nas formas básicas ou sais farmaceuticamente aceitáveis
US20040001889A1 (en) 2002-06-25 2004-01-01 Guohua Chen Short duration depot formulations
ATE482695T1 (de) 2002-12-13 2010-10-15 Durect Corp Orale darreichungsform mit flüssigen hochviskosen trägersystemen
LT2767292T (lt) 2004-09-17 2016-12-12 Durect Corporation Palaikomosios vietinės anestezijos mišinys su saib
US20070027105A1 (en) 2005-07-26 2007-02-01 Alza Corporation Peroxide removal from drug delivery vehicle
DK2117521T3 (da) 2006-11-03 2012-09-03 Durect Corp Transdermale indgivelsessystemer omfattende bupivacain
AU2008335809A1 (en) 2007-12-06 2009-06-18 Durect Corporation Methods useful for the treatment of pain, arthritic conditions, or inflammation associated with a chronic condition
US20100260844A1 (en) 2008-11-03 2010-10-14 Scicinski Jan J Oral pharmaceutical dosage forms
CN102093284B (zh) * 2010-12-29 2013-05-08 宜昌人福药业有限责任公司 富集哌啶-2-甲酰苯胺类旋光化合物的方法
TW201521769A (zh) 2013-03-15 2015-06-16 Durect Corp 具有流變改質劑以減少溶解變異性之組成物
CN106187864B (zh) * 2016-07-11 2018-11-23 江苏天和制药有限公司 一种由盐酸布比卡因制备高纯度布比卡因碱的方法
BR112022013784A2 (pt) 2020-01-13 2022-10-11 Durect Corp Sistemas de distribuição de fármacos de liberação prolongada com impurezas reduzidas e métodos relacionados
WO2023158722A2 (en) * 2022-02-16 2023-08-24 Teva Pharmaceuticals International Gmbh Processes for preparation of avacopan and intermediates thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2301498A1 (fr) * 1975-02-20 1976-09-17 Maggioni & C Spa Methode pour la racemisation d'une lysine optiquement active

Also Published As

Publication number Publication date
DE69628540D1 (de) 2003-07-10
JPH11501905A (ja) 1999-02-16
NO973312D0 (no) 1997-07-17
MX9705428A (es) 1997-11-29
ATE242214T1 (de) 2003-06-15
KR100404390B1 (ko) 2004-01-31
NO973312L (no) 1997-07-17
HUP9901418A3 (en) 2001-01-29
AU4394896A (en) 1996-08-07
KR19980701432A (ko) 1998-05-15
NO308843B1 (no) 2000-11-06
CN1168134A (zh) 1997-12-17
PT804417E (pt) 2003-09-30
BR9606821A (pt) 1997-12-23
HUP9901418A2 (hu) 1999-08-30
EP0804417A1 (en) 1997-11-05
GB9501071D0 (en) 1995-03-08
DE69628540T2 (de) 2004-01-08
FI973040A0 (fi) 1997-07-17
EP0804417B1 (en) 2003-06-04
CN1172912C (zh) 2004-10-27
DK0804417T3 (da) 2003-10-06
CA2208522A1 (en) 1996-07-25
PL321378A1 (en) 1997-12-08
FI117437B (fi) 2006-10-13
HU227426B1 (en) 2011-05-30
WO1996022281A1 (en) 1996-07-25
AU701221B2 (en) 1999-01-21
FI973040A (fi) 1997-07-17
CA2208522C (en) 2007-03-13
PL184091B1 (pl) 2002-08-30
JP4015696B2 (ja) 2007-11-28
ES2201166T3 (es) 2004-03-16

Similar Documents

Publication Publication Date Title
ZA96403B (en) Racemisation
UA32566C2 (uk) Спосіб одержання штаму мікроорганізму, спосіб продукування триптофану
EP0861262A4 (en) GROUPS FOR CATCHING NUCLEIC ACIDS
DE69711632D1 (de) Methode zur dissoziation von biotin komplexen
PT828717E (pt) Metodo de preparacao de 3-haloalquil-1h-pirazoles
AU3738597A (en) Molecular model for vla-4 inhibitors
ATE335511T1 (de) Ein verfahren zur inhibierung der komplementaktivierung über einen alternativen weg
MX9803377A (es) Metodo de transmision de informacion y aparato de codificiacion/descodificacion y aparato de codificicacion-multiplexion/descodificacion-desmultiplexion en sistema de transmision de informacion al cual se aplica el metodo de transmision de informacio
FI980862A (fi) Kiraalisia metyylifenyylioksatsolidinoneja
ATE317912T1 (de) Verfahren zur herstellung von beta-lactamen
DE69710051D1 (de) Auflösungsverfahren von threo-methylphenidate
DE69637771D1 (de) Eine verbesserte immobilisierte penicillin g acylase
CA2291170A1 (en) Processes and intermediates for resolving piperidyl acetamide stereoisomers
HUP0003203A2 (hu) Eljárás bisz-indolil-maleimidek előállítására
SE9501808D0 (sv) New process
AU1278801A (en) Method for generating information related to the molecular structure of a biomolecule
DE59702009D1 (de) Verfahren zur herstellung von 1,4,7,10-tetraazacyclododecan und dessen derivaten
ATE213782T1 (de) Verfahren zur biotransformation von colchicinoid- verbindungen in die entsprechenden 3- glycosylderivate
HUP0002709A1 (hu) Eljárás 1-helyzetben szubsztituált 4-(4-fluor-fenil)-3-(hidroxi-metil)-tetrahidropiridinek redukciójára
NO20021549L (no) Transformanter av en mikroorganisme som produserer en metabolitt, samt fremgangsmate for samme, og fremgangsmate for a produsere et substans PF1022-derivat
IL150638A0 (en) Pseudopolymorph of (-)-cis-2-(2-chlorophenyl)-5,7-dihydroxy-8 [4r-(3s-hydroxy-1-methyl)piperidinyl]-4h-1-benzopyran-4-one
AU6468099A (en) Accelerator for the production of polyamides from aminonitriles
ATE301625T1 (de) Verfahren zur herstellung von 2,6- dimethylnaphthalin
ATE256689T1 (de) Verfahren zur herstellung von ascorbinsaüre-2- monophosphat salz
DE58906674D1 (de) Verfahren zur Auswahl produktiver, Aminosäuren ausscheidender Stämme von Mikroorganismen.